Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 72.76 -1.11%   SPY: 163.45 -1.38%
Quote Spy AMGN NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Amgen (AMGN)

@ Jun-19
Click the portfolio to add AMGN:
Close [X]
+ Add AMGN to Portfolio
  
  Last Trade: $99.18 -2.32 (-2.29%)
  Volume: 3,825,420 115% of avg daily volume
       
  Avg Volume: 3,328,655
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 99.15 - 102.00
  Open: 101.69
  Previous Close: 101.50
  52-wk Range: 70.88 - 114.95
  Market Cap: 74.3B
  P/E: 17.1
  Div Yield: $0.47 (1.85%)
Indexes
Big Pharmaceutical S... (-1.7%)
Biotechnology Stocks (-1.7%)
Spy AMGN

? Pro holders
? Member holders
? Items submitted
Additional AMGN resources



Customize Links
To see which Pros and tickerspy members own AMGN Sign up now
Latest AMGN Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Interesting Similarities Among 2013's Top-Performing ETFs
PFE  MRK  AMGN  GEX  IBB  CSD  TSLA  BBH  SCTY  XLV  PBW  PBE  XPH  TAN  ICLN  KWT  
Linked by Benzinga.com - June 18, 04:09PM from (www.benzinga.com)
With 2013 nearly half complete, now is a good time to look at this year's top-performing ETFs to see what has worked, what  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Barron's Recap: Midyear Roundtable
AMD  BBT  AMGN  BIG  EMN  IRM  LINE  
Linked by Benzinga.com - June 17, 10:50AM from (www.benzinga.com)
This past weekend in Barron's online: the midyear 2013 roundtable, and the prospects for Eastman Chemical, BB&T, Amgen and Big Lots.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
New Amgen Drug Receives FDA Approval
AMGN  
Linked by The Dividend Daily - June 13, 04:34PM from (www.dividend.com)
Biopharmaceutical firm Amgen (AMGN) has just had a major new drug, called "XGEVA," approved by the FDA. XGEVA will be used  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amgen’s AMG-386 Still Not Meeting FDA Standards
AMGN  
Linked by The Dividend Daily - June 12, 04:40PM from (www.dividend.com)
California bio-pharmaceutical company Amgen (AMGN) will likely need to make more improvements to its ovarian cancer drug,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Interest Falls in Vertex, Rises in Biogen Idec
BMY  PFE  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  NVS  
Linked by Benzinga.com - June 12, 01:29PM from (www.benzinga.com)
Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB), saw the most significant rise in short interest  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Deutsche Bank Maintains “Buy” Rating on Amgen
AMGN  
Linked by The Dividend Daily - June 12, 01:03PM from (www.dividend.com)
Deutsche Bank reported on Wednesday that it has reiterated a "Buy" rating on biotechnology company, Amgen, Inc. (AMGN). The  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
An Experimental Drug’s Bitter End
AMGN  NVS  FB  
Linked by NYTimes - June 06, 09:20PM from (www.nytimes.com)
Parents are fighting to keep a drug to treat autism and fragile X syndrome that failed clinical trials on the market because  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Dividend Highlights/Lowlights for May 31
CAJ  CMI  GPS  PLL  PFE  TJX  GWW  AMGN  IEP  ABBV  
Linked by The Dividend Daily - May 31, 04:59PM from (www.dividend.com)
These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Interest in Vertex Rises, in Biogen Idec Falls
BMY  PFE  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  NVS  
Linked by Benzinga.com - May 29, 01:19PM from (www.benzinga.com)
Among biotech and emerging pharmaceutical companies, Regeneron Pharmaceuticals (NASDAQ: REGN) and Vertex Pharmaceuticals  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amgen Partners With Japanese Drug Maker
AMGN  
Linked by The Dividend Daily - May 29, 08:35AM from (www.dividend.com)
Early on Wednesday, the world's largest biotechnology company Amgen, Inc. (AMGN) said it has entered an agreement with Japanese  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 61



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource